clarithromycin has been researched along with Adenocarcinoma in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (22.22) | 18.2507 |
2000's | 15 (55.56) | 29.6817 |
2010's | 5 (18.52) | 24.3611 |
2020's | 1 (3.70) | 2.80 |
Authors | Studies |
---|---|
Desai, T; Edhi, AI; Hakim, S | 1 |
Graham, DY; Howden, CW | 1 |
Keller, PM; Redondo, JJ; Wagner, K; Zbinden, R | 1 |
Hashimoto, Y; Hiki, N; Honda, M; Kamiya, S; Kumagai, K; Mine, S; Nunobe, S; Ohashi, M; Sano, T; Yamaguchi, T | 1 |
Hillard, JR; Laird-Fick, HS; Saini, S | 1 |
Becquart, JP; Camuset, G; Gérardin, P; Guillemot, G; Jaubert, J; Kwiatek, S; Michault, A; Picot, S; Thomas, E; Zemali, N | 1 |
Figueroa, LS; Guarner, J; Halperin, D; Herrera-Goepfert, R; Ley, C; Mohar, A; Parsonnet, J | 1 |
Schuster, MJ | 1 |
Arima, N; Tsudo, M | 1 |
Aiba, M; Hamaguchi, K; Katsube, T; Konno, S; Ogawa, K | 1 |
Schuster, M | 1 |
Hara, H; Miyokawa, N; Ohtubo, C; Sano, H; Tanabe, H | 1 |
Arao, T; Hirama, N; Inoue, S; Kubota, I; Machiya, J; Sata, M; Sato, J; Shibata, Y; Takabatake, N; Tokairin, Y; Wada, T | 1 |
Bertoli Neto, JL; Bertoli, CF; Bueno, AG; Lourenço, LG; Sabbi, AR; Ulbrich, FS | 1 |
Haruma, K; Iishi, H; Ishiguro, S; Kamada, T; Merchant, JL; Nakae, Y; Shiotani, A; Tatsuta, M; Uedo, N | 1 |
Harris, EJ; Krishna, U; Peek, RM; Perez-Perez, GI; Romero-Gallo, J; Washington, MK | 1 |
Isomoto, H; Kohno, S; Matsunaga, K; Mizuta, Y; Oofukuji, M; Osabe, M; Syukuwa, S; Takeno, Y | 1 |
Hamada, K; Kita, E; Konishi, M; Maeda, K; Mikasa, K; Mori, K; Narita, N; Sakamoto, M; Sawaki, M; Teramoto, S; Tsujimoto, M | 1 |
Fukuoka, K; Hamada, K; Kataoka, T; Kita, E; Konishi, M; Maeda, K; Mikasa, K; Mori, K; Narita, N; Sakamoto, M; Sawaki, M; Segawa, K; Teramoto, S; Tsujimoto, M; Ueda, K | 1 |
Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Mori, K; Narita, N; Sakamoto, M; Sawaki, M; Teramoto, S; Tsujimoto, M; Ueta, K | 1 |
Fujishita, T; Kobayashi, M; Mizushima, Y; Oosaki, R; Sassa, K | 1 |
Kobayashi, M; Mizushima, Y; Sassa, K | 1 |
Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Murakawa, K; Narita, N; Sakamoto, M; Takahashi, K; Yoshimoto, E | 1 |
Adamsson, I; Edlund, C; Nord, CE | 1 |
Mikasa, K | 1 |
Bigard, MA | 1 |
Ebata, M; Keto, Y; Okabe, S | 1 |
7 review(s) available for clarithromycin and Adenocarcinoma
Article | Year |
---|---|
Gastric adenocarcinoma: the role of Helicobacter pylori in pathogenesis and prevention efforts.
Topics: Adenocarcinoma; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Early Detection of Cancer; Helicobacter Infections; Helicobacter pylori; Humans; Mass Screening; Prevalence; Primary Prevention; Proton Pump Inhibitors; Risk Assessment; Socioeconomic Factors; Stomach Neoplasms | 2016 |
[Helicobacter pylori. Update 2002].
Topics: Adenocarcinoma; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Follow-Up Studies; Gastritis, Atrophic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Risk; Risk Factors; Stomach Neoplasms; Stomach Ulcer; Time Factors | 2002 |
Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Omeprazole; Stomach Neoplasms; Thyroid Neoplasms; Thyroiditis, Autoimmune | 2003 |
[Helicobacter pylori: reasons for eradication].
Topics: Adenocarcinoma; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Risk Factors; Secondary Prevention; Stomach Neoplasms | 2004 |
Microbial ecology and treatment of Helicobacter pylori infections: review.
Topics: Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Female; Gastric Mucosa; Gastritis; Genetic Variation; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Stomach Neoplasms | 2000 |
[Helicobacter pylori eradication. Therapeutic evolution, value of complementary studies].
Topics: Adenocarcinoma; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Stomach Neoplasms | 2001 |
[Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils].
Topics: Adenocarcinoma; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Indomethacin; Omeprazole; Recurrence; Stomach Neoplasms; Stomach Ulcer | 2001 |
4 trial(s) available for clarithromycin and Adenocarcinoma
Article | Year |
---|---|
Preoperative vs Postoperative Eradication of Helicobacter pylori in 150 Patients with Gastric Cancer: A Randomized Controlled Trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Postoperative Care; Preoperative Care; Proton Pump Inhibitors; Stomach Neoplasms; Treatment Outcome | 2015 |
Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure.
Topics: Adenocarcinoma; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Gastrins; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Penicillins; Precancerous Conditions; Recurrence; Risk Factors; ROC Curve; Stomach Neoplasms | 2002 |
[Efficacy of clarithromycin (CAM) in patients with inoperable non-small-cell lung cancer].
Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Clarithromycin; Female; Humans; Immunologic Factors; Interleukin-6; Lung Neoplasms; Male; Middle Aged | 1998 |
[Study of effects and mechanisms of macrolide as biological response modifier for lung cancer treatment].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Clarithromycin; Cytokines; Female; Humans; Immunologic Factors; Killer Cells, Natural; Lung Neoplasms; Male; Middle Aged; Treatment Outcome | 2000 |
16 other study(ies) available for clarithromycin and Adenocarcinoma
Article | Year |
---|---|
Eradicating H. pylori.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Drug Therapy, Combination; Esophageal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Mortality; Myocardial Infarction; Patient Selection; Practice Guidelines as Topic; Quinolones; Risk; Risk Assessment; Stomach Neoplasms; United States | 2019 |
Recent Developments Pertaining to H. pylori Infection.
Topics: Adenocarcinoma; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Pyrroles; Rifabutin; Stomach Neoplasms; Sulfonamides; Tetracycline; Treatment Outcome | 2021 |
A novel RT-PCR for the detection of Helicobacter pylori and identification of clarithromycin resistance mediated by mutations in the 23S rRNA gene.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Point Mutation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Ribosomal, 23S; Stomach Neoplasms | 2018 |
Helicobacter pylori resistance to clarithromycin in Reunion Island.
Topics: Adenocarcinoma; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Gastric Fundus; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Metaplasia; Mutation; Proton Pump Inhibitors; Pyloric Antrum; Reunion; Stomach Neoplasms | 2016 |
Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cell Transformation, Neoplastic; Clarithromycin; Female; Gastrectomy; Gastric Mucosa; Gastroenterostomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Neoplasm Recurrence, Local; Omeprazole; Stomach Neoplasms; Treatment Outcome | 2004 |
[Disappearance of gastric adenocarcinoma in hyperplastic polyp after eradication of Heliobacter pylori. Report of a case].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Polyps; Stomach Neoplasms | 2005 |
Clarithromycin suppresses invasiveness of human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Clarithromycin; Humans; Integrin alpha2; Integrin beta1; Lung Neoplasms; Mice; Neoplasm Invasiveness; NIH 3T3 Cells; Thymidine Phosphorylase | 2007 |
Evaluation of the efficacy of triple therapy regimen for Helicobacter pylori eradication in gastrectomized patients with gastric adenocarcinoma.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Female; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Stomach Neoplasms | 2006 |
Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia.
Topics: Adenocarcinoma; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarkers, Tumor; Case-Control Studies; CDX2 Transcription Factor; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Hedgehog Proteins; Helicobacter Infections; Helicobacter pylori; Homeodomain Proteins; Humans; Immunohistochemistry; Intestinal Mucosa; Male; Metaplasia; Middle Aged; Pepsinogen A; Precancerous Conditions; Stomach Neoplasms | 2007 |
Effect of Helicobacter pylori eradication on gastric carcinogenesis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Amoxicillin; Animals; Animals, Outbred Strains; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Interferon-gamma; Lansoprazole; Male; Specific Pathogen-Free Organisms; Stomach Neoplasms; Time Factors | 2008 |
[Successful eradication of H. pylori in an elderly patient with gastric cancer after effective UFT-E therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adenocarcinoma; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Diterpenes; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Stomach Neoplasms; Tegafur; Uracil | 1997 |
[Fluctuation in the cytokine m-RNA content in primary non-small cell lung cancer caused by clarithromycin (CAM) administration].
Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Clarithromycin; Female; Humans; Immunologic Factors; Interleukin-12; Lung Neoplasms; Male; RNA, Messenger | 1997 |
[Effect of clarithromycin on prolonging the life expectancy of patients with primary lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Anti-Bacterial Agents; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Clarithromycin; Female; Humans; Immunologic Factors; Lung Neoplasms; Male; Middle Aged; Survival Rate | 1997 |
Therapeutic effect of clarithromycin on a transplanted tumor in rats.
Topics: Adenocarcinoma; Animals; Chromium Radioisotopes; Clarithromycin; Collagenases; Coloring Agents; Cytotoxicity, Immunologic; Humans; Interleukin-6; Male; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 9; Neoplasm Transplantation; Rats; Rats, Inbred F344; Spleen; Tetrazolium Salts; Thiazoles; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1999 |
Differential modulatory effects of clarithromycin on the production of cytokines by a tumor.
Topics: Adenocarcinoma; Animals; Anti-Bacterial Agents; Clarithromycin; Cytokines; Depression, Chemical; Gelatin; Interleukin-6; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 9; Protein Synthesis Inhibitors; Rats; RNA; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1999 |
[Administration of clarithromycin (CAM) to non-small cell lung cancer].
Topics: Adenocarcinoma; Aged; Animals; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Clarithromycin; Disease Models, Animal; Female; Humans; Immunologic Factors; Interferon-gamma; Interleukin-10; Interleukin-12; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL | 2000 |